Literature DB >> 1719382

Differential effect of 5 alpha-reductase inhibition and castration on androgen-regulated gene expression in rat prostate.

R S Rittmaster1, K E Magor, A P Manning, R W Norman, C B Lazier.   

Abstract

Castration reduces prostate size and causes intraprostatic testosterone (T) and dihydrotestosterone (DHT) to fall to very low levels. 5 alpha-Reductase inhibition also reduces prostate size, but results in a marked increase in intraprostatic T levels. To compare the effects of 5 alpha-reductase inhibition and castration on prostate physiology, male Sprague-Dawley rats were left intact, castrated, or given the selective 5 alpha-reductase inhibitor finasteride for up to 9 days. To be sure that finasteride itself did not directly affect gene expression, an additional group of rats was castrated and given finasteride for 4 days. The prostates were weighed, intraprostatic RNA, DNA, and androgen levels were measured, and mRNAs for two androgen-regulated genes, prostate steroid-binding protein (PSBP; an androgen-induced gene) and testosterone-repressed prostate message (TRPM-2), were quantitated by Northern and slot blot analyses. Finasteride caused a 95% reduction in intraprostatic DHT levels and a 10-fold increase in intraprostatic T levels. Finasteride, as expected, caused a pronounced decrease in prostate weight (45% on day 4). DNA content fell correspondingly (48% on day 4). Intraprostatic DNA (micrograms of DNA per gland) on day 4 was 328 +/- 53 in control rats, 171 +/- 10 in finasteride-treated rats (P less than 0.001 compared to controls), 115 +/- 2 in castrated rats (P less than 0.05 compared to finasteride), and 107 +/- 43 in finasteride-treated plus castrated rats (P = NS compared to castration alone). There were no significant differences in DNA levels among the groups when expressed per mg prostate tissue, indicating that mean prostate cell size was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719382     DOI: 10.1210/mend-5-7-1023

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.

Authors:  S S Dadras; X Cai; I Abasolo; Z Wang
Journal:  Gene Expr       Date:  2001

Review 2.  Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?

Authors:  Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

3.  New options for patients with benign prostatic hyperplasia.

Authors:  B Ellenberger
Journal:  CMAJ       Date:  1993-02-15       Impact factor: 8.262

Review 4.  Differing levels of testosterone and the prostate: a physiological interplay.

Authors:  S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

5.  Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.

Authors:  Tyler M Bauman; Priyanka D Sehgal; Karen A Johnson; Thomas Pier; Reginald C Bruskewitz; William A Ricke; Wei Huang
Journal:  Prostate       Date:  2014-04-30       Impact factor: 4.104

6.  Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.

Authors:  A S Wright; L N Thomas; R C Douglas; C B Lazier; R S Rittmaster
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

Review 7.  Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia.

Authors:  D H Peters; E M Sorkin
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.